Clinicopathological improvement of non-alcoholic steatohepatitis associated with weight loss during a 14-year follow-up period

Liver International

Volumn 27, Issue 10, 2007, Pages 1422-1427

  Nishide, Tomohiro ^a,b   Ikeda, Kenji ^a,b   Kawamura, Yusuke ^a,b   Hosaka, Tetsuya ^a,b   Kobayashi, Masahiro ^a,b   Suzuki, Yoshiyuki ^a,b   Kumada, Hiromitsu ^a,b  

^a TORANOMON HOSPITAL   (Japan)

^b Okinaka Memorial Institute for Medical Research   (Japan)

Author keywords

Body weight loss; Improvement; Non alcoholic steatohepatitis

Indexed keywords

ACARBOSE; ADIPONECTIN; AMINOTRANSFERASE; AMLODIPINE; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; CALCIUM CHANNEL BLOCKING AGENT; CANDESARTAN; CHOLESTEROL; GLIBENCLAMIDE; HYALURONIC ACID; NICARDIPINE; SULFONYLUREA; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY WEIGHT; CASE REPORT; DISEASE SEVERITY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HOSPITAL ADMISSION; HUMAN; HUMAN TISSUE; HYPERTENSION; LABORATORY TEST; LAPAROSCOPY; LIVER BIOPSY; LIVER FUNCTION TEST; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; OBESITY; WEIGHT REDUCTION;

ADULT; BIOPSY; DIABETES MELLITUS, TYPE 2; DIET, REDUCING; FATTY LIVER; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; OBESITY; WEIGHT LOSS;

EID: 36348953793     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2007.01574.x     Document Type: Article

References (20)

1. Ludwig J, Viggiano TR, McGill DB, Ott BJ. Nonalcoholic steatohepatitis: mayo clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 1980; 55: 434-8.
2. Bacon BR, Farahvash MJ, Janney CG, Neuschwander-Tetri BA. Nonalcoholic steatohepatitis: An expanded clinical entity. Gastroenterol 1994; 107: 1103-9.
3. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002; 346: 1221-31.
4. Clark JM, Brancati FL, Diehl AM. Nonalcoholic fatty liver disease. Gastroenterol 2002; 122: 1649-57.
5. Neuschwander-Tetri BA, Caldwell SH. Nonalcoholic steatohepatitis: summary of an AASLD single topic conference. Hepatology 2003; 37: 1202-19.
6. Clinical Practice Committee and the American Association for the Study of Liver Diseases (AASLD) Practice Guidelines Committee. AGA technical review on nonalcoholic fatty liver disease. Gastroenterol 2002; 123: 1705-25.
7. Andrea ER. Nonalcoholic steatohepatitis. Gastroenterology 2001; 121: 710-23.
8. James OFW, Day CP. Non-alcoholic steatohepatitis (NASH): A disease of emerging identity and importance. J Hepatol 1998; 29: 495-501.
9. Younossi ZM, Diehl AM, Ong JP. Nonalcoholic fatty liver disease: An agenda for clinical research. Hepatology 2002; 35: 746-52.
10. Ratziu V, Giral P, Charlotte F, et al. Liver fibrosis in overweight patients. Gastroenterology 2000; 118: 1117-23.
11. Angulo P, Keach JC, Batts KP, Lindor KD. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology 1999; 30: 1356-62.
12. Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: A proposal for grading and staging the histological lesions. Am J Gastroenterol 1999; 94: 2467-74.
13. Powell E, Cooksley W, Hanson R, Searle J, Halliday JW, Powell LW. The natural history of nonalcoholic steatohepatitis: A follow-up study of forty-two patients for up to 21 years. Hepatology 1990; 11: 74-80.
14. Eduardo F, Estela A, Nora D, Graciela L, Cristina L. Natural history of nonalcoholic steatohepatitis: A longitudinal study of repeat liver biopsies. Hepatology 2004; 40: 820-6.
15. John BD, Prithi SB, Norman RH, Paul EO. Nonalcoholic fatty liver disease: Improvement in liver histological analysis with weight loss. Hepatology 2004; 39: 1647-54.
16. Fujikawa K, Ohata K, Honda T, et al. Nonalcoholic steatohepatitis with improved hepatic fibrosis after weight reduction. Intern Med 2004; 43: 289-94.
17. Pagliaro L, Rinaldi F, Craxi A, et al. Percutaneous blind biopsy versus laparoscopy with guided biopsy in diagnosis of cirrhosis. A prospective, randomized trial. Dig Dis Sci 1983; 28: 39-43.
18. Orlando R, Lirussi F, Okolicsnyi L. Laparoscopy and liver biopsy: further evidence that the two procedures improve the diagnosis of liver cirrhosis. A retrospective study of 1,003 consecutive examinations. J Clin Gastroenterol 1990; 12: 47-52.
19. Colloredo G, Guido M, Sonzogni A, Leandro G. Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: The smaller the sample, the milder the disease. J Hepatol 2003; 39: 2239-44.
20. Ratziu V, Charlotte F, Heurtier A, et al. Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology 2005; 128: 1898-906.